Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("INTERACTION TABAC MEDICAMENT")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 124

  • Page / 5

Export

Selection :

  • and

CODEINE DISPOSITION IN SMOKERS AND NONSMOKERSROGERS JF; FINDLAY JWA; HULL JH et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 2; PP. 218-227; BIBL. 35 REF.Article

CIGARETTE SMOKING AND SUBJECTIVE RESPONSE: EFFECTS OF D-AMPHETAMINEHENNINGFIELD JE; GRIFFITHS RR.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 30; NO 4; PP. 497-505; BIBL. 26 REF.Article

LES EFFETS DU TABAC ET/OU DE L'ALCOOL SUR LE METABOLISME DES MEDICAMENTSVANDEL B.1983; GAZETTE MEDICALE DE FRANCE (1969); ISSN 0016-5557; FRA; DA. 1983; VOL. 90; NO 7; PP. 559-564; 4 P.; ABS. ENG; BIBL. 19 REF.Article

THE INFLUENCE OF CIGARETTE SMOKING ON BLOOD GOLD DISTRIBUTION DURING CHRYSOTHERAPYJAMES DW; LUDVIGSEN NW; CLELAND LG et al.1982; J. RHEUMATOL.; ISSN 0315-162X; CAN; DA. 1982; VOL. 9; NO 4; PP. 532-535; BIBL. 15 REF.Article

THE EFFECT OF SMOKING ON THE DISTRIBUTION OF GOLD IN BLOODGRAHAM GG; HAAVISTO TM; MCNAUGHT PJ et al.1982; J. RHEUMATOL.; ISSN 0315-162X; CAN; DA. 1982; VOL. 9; NO 4; PP. 527-531; BIBL. 24 REF.Article

CIGARETTE SMOKING AND CHLORPROMAZINE DISPOSITION AND ACTIONSPANTUCK EJ; PANTUCK CB; ANDERSON KE et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 4; PP. 533-538; BIBL. 37 REF.Article

CIGARETTE SMOKING DOES NOT ATTENUATE THE CARDIOVASCULAR EFFECTS OF EPOPROSTENOL (PROSTACYCLIN) IN HUMANSHASSAN S; MACDOUGALL IC; O'GRADY J et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 14; NO 1; PP. 97-98; BIBL. 4 REF.Article

CIGARETTE SMOKING AND THEOPHYLLINE CLEARANCE AND METABOLISMGRYGIEL JJ; BIRKETT DJ.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 30; NO 4; PP. 491-496; BIBL. 7 REF.Article

SMOKING AND DRUG METABOLISMDAWSON GW; VESTAL RE.1981; PHARMACOL. THER.; ISSN 0163-7258; USA; DA. 1981 PUBL. 1982; VOL. 15; NO 2; PP. 207-221; BIBL. 4 P.Article

SMOKING IMPAIRS THERAPEUTIC GASTRIC INHIBITIONBOYD EJ; WILSON TA; WORMSLEY KG et al.1983; LANCET (THE). (BRITISH EDITION); ISSN 0140-6736; GBR; DA. 1983; NO 8316; PP. 95-97; BIBL. 12 REF.Article

INTERACTION BETWEEN CIGARETTES AND PROPRANOLOL IN TREATMENT OF ANGINA PECTORISFOX K; JONATHAN A; WILLIAMS H et al.1980; BRIT. MED. J.; GBR; DA. 1980; NO 6234; PP. 191-193; BIBL. 12 REF.Article

PHARMACOKINETICS OF N-DESMETHYLDIAZEPAM AFTER A SINGLE ORAL DOSE OF CLORAZEPATE: THE EFFECTS OF SMOKINGNORMAN TR; FULTON A; MAGUIRE KP et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 21; NO 3; PP. 229-233; BIBL. 19 REF.Article

AGING, CIGARETTE SMOKING AND ORAL THEOPHYLLINE REQUIREMENTTALSETH T; BOYE NP; KONGERUD J et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 21; NO 1; PP. 33-37; BIBL. 21 REF.Article

EFFECTS OF SMOKING ON PHENYLBUTAZONE DISPOSITIONGARG SK; RAVIKIRAN TN.1982; INT. J. PHARMACOL. TOXICOL.; ISSN 506508; DEU; DA. 1982; VOL. 20; NO 6; PP. 289-290; BIBL. 23 REF.Article

Smokers need higher doses of neuroleptic drugsVINAROVA, E; VINAR, O; KALVACH, Z et al.Biological psychiatry (1969). 1984, Vol 19, Num 8, pp 1265-1268, issn 0006-3223Article

Tabac et médicaments : liaisons dangereuses ? = Smoking and medicinal products : dangerous liaisons ?GAUDONEIX-TAIEB, Muriel; BEAUVERIE, Patrick; POISSON, Nicole et al.Alcoologie et addictologie. 2001, Vol 23, Num 1, pp 7-12, issn 1620-4522Article

Nicotine exposure and tardive dyskinesiaRAMZY YASSA; SAMARTHJI LAL; KORPASSY, A et al.Biological psychiatry (1969). 1987, Vol 22, Num 1, pp 67-72, issn 0006-3223Article

Effect of cigarette smoking on mexiletine kineticsGRECH-BELANGER, O; GILBERT, M; TURGEON, J et al.Clinical pharmacology and therapeutics. 1985, Vol 37, Num 6, pp 638-643, issn 0009-9236Article

Influence du tabac sur les taux sériques et la pharmacocinétique de la phénylbutazone et de l'oxyphenbutazone = Influence of tobacco on the serum levels and the pharmacokinetics of phenylbutazone and oxyphenbutazoneQUENEAU, P; OLLAGNIER, M; DECOUSUS, H et al.Revue du rhumatisme et des maladies ostéo-articulaires. 1983, Vol 50, Num 4, pp 293-297, issn 0035-2659Article

Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case reportSTIMMEL, G. L; FALLOON, I. R. H.The Journal of clinical psychiatry. 1983, Vol 44, Num 11, pp 420-422, issn 0160-6689Article

Médicaments, alcool et tabac = Drug, alcohol and tobaccoTALBERT, M.Journal de pharmacie clinique (Paris). 1992, Vol 11, Num 1, pp 23-27, issn 0291-1981Article

The effect of acetylsalicylic acid on the outcome after lower limb arterial surgery with special reference to cigarette smoking. CommentaryLASSILA, R; LEPANTALO, M; LINDFORS, O et al.World journal of surgery. 1991, Vol 15, Num 3, pp 378-382, issn 0364-2313Article

Absence of effect of cigarette smoking on serum concentrations of some anticonvulsants in epileptic patientsBENETELLO, P; FURLANUT, M; PASQUI, L et al.Clinical pharmacokinetics. 1987, Vol 12, Num 4, pp 302-304, issn 0312-5963Article

Effects of mecamylamine on human cigarette smoking and subjective ratingsNEMETH-COSLETT, R; HENNINGFIELD, J. E; O'KEEFFE, M. K et al.Psychopharmacologia. 1986, Vol 88, Num 4, pp 420-425, issn 0033-3158Article

Effects of smoking on fluphenazine clearance in psychiatric inpatientsERESHEFSKY, L; JANN, M. W; SAKLAD, S. R et al.Biological psychiatry (1969). 1985, Vol 20, Num 3, pp 329-332, issn 0006-3223Article

  • Page / 5